Ángel Castaño

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Ángela Lamarca et al. · Journal of Clinical Oncology · 2019 · 76 citations · Full text

Medicine, Endocrinology, Oncology +14

Prognostic Factors and Long-Term Outcome of Pancreatic Neuroendocrine Neoplasms: Ki-67 Index Shows a Greater Impact on Survival than Disease Stage. The Large Experience of the Spanish National Tumor Registry (RGETNE)

Elena Martín‐Pérez, Jaume Capdevila, Daniel Castellano et al. · Neuroendocrinology · 2013 · 72 citations · Full text

Medicine, Oncology, Surgery +17

Prognostic value of KIT expression in small cell lung cancer

Ana López, Claudio Ballestı́n, Rocio García‐Carbonero et al. · Lung Cancer · 2007 · 41 citations

Medicine, Molecular Biology, Oncology +15

A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples

Beatriz Sánchez‐Espiridión, Abel Sánchez‐Aguilera, Carlos Montalbán et al. · Clinical Cancer Research · 2009 · 37 citations

Medicine, Cancer Biology, Oncology +17

The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms

Ivan Borbath, Rocio García‐Carbonero, Damir Bikmukhametov et al. · European Journal of Cancer · 2022 · 35 citations

Medicine, Oncology, Pathology +14